Nakagawa Y

ORCID: 0000-0003-4103-2423 · 2 papers in corpus

nonrandomized-trial 2024

Phase I study of the safety and clinical activity of the interleukin-8 inhibitor AMY109 combined with atezolizumab in patients with advanced solid cancers

Journal for immunotherapy of cancer ·doi:10.1136/jitc-2024-009262

BACKGROUND: Immunosuppressive conditions within the tumor microenvironment (TME) can allow tumors to evade the immune system, including by hampering programmed death ligand 1 (PD-L1) inhibitor activity. Interleukin (IL)-8 contributes to imm…

other 2018

Lack of a meaningful association between dietary patterns and in vitro fertilization outcome among Japanese women

Reproductive medicine and biology ·doi:10.1002/rmb2.12223

PURPOSE: The purpose of this study was to examine whether preconception maternal dietary pattern is associated with in vitro fertilization (IVF) outcome among Japanese women. METHODS: This prospective study included 140 Japanese women who …